Can the U.S. finally slow down China’s takeover of aluminum?
An employee works at an aluminum products factory in Huaibei, Anhui. Credit: Li Xin/VCG via Getty Images
It was a complex scheme for a simple crime: With dozens of shell corporations, a gargantuan aluminum stockpile in the central Mexican countryside and several warehouses scattered across Los Angeles and New Jersey ports, the Chinese aluminum firm Zhongwang Holdings successfully avoided U.S. tariffs for at least four years, defrauding the American government out of $1.8 billion.
Liu Zhongtian toasts during the ceremony for Zhongwang Holdings' listing on the Hong Kong Stock Exchange, May 8, 2009
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
When Congress resumes next month, the BioSecure Act will be one of its top priorities. The bill, which could dramatically reorder the global pharmaceutical supply chain, is the latest example of the U.S. trying to exorcize China from its supply chains, and it will have a profound effect on WuXi Apptec, the most important drugmaker American patients have never heard of.
The economics journalist talks about his travels to see how the substances we need for modern life are extracted and produced, the trade-offs involved and the fragility of so many of the supply chains and...
September 17th: Strategies for Identifying Military End Users
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy